semaglutide advertising Weight loss Super Bowl ad sparks controversy Achieve your weight loss goals

By week 2 to 3, side effects from the initiation dose should be minimal

UC study: Drug safe, effective for weight loss in patients with stable bipolar disorder Results published in Journal of Clinical Psychopharmacology A clinical trial led by University of Cincinnati researchers at the Lindner Center of HOPE found a drug was safe and effective for weight loss for patients with stable bipolar disorder

Persistent bad breath can indicate underlying dental problems such as gum disease, tooth decay, oral infections, or tonsil stones that require professional treatment

Semaglutide is the prescription medication sold as Ozempic and is also the same medication, but in higher doses, marketed as Wegovy and used for weight loss

It is not a controlled substance under the Controlled Drugs and Substances Act

Patients should seek immediate medical attention when signs or symptoms of weight loss occur